Brief: RepliCel Life Sciences Lands Commitment For Key Investment Partnership
16/01/2018 11:01
Jan 16 (Reuters) - Replicel Life Sciences Inc RP.V :
* REPLICEL LIFE SCIENCES LANDS COMMITMENT FOR KEY INVESTMENT
PARTNERSHIP
* REPLICEL LIFE SCIENCES SAYS DEAL REFLECTED IN TERM SHEET
INVOLVES UP-FRONT INVESTMENT OF $6.5 MILLION
* REPLICEL LIFE SCIENCES - SIGNED BINDING TERM SHEET WITH
YOFOTO
(CHINA) HEALTH INDUSTRY TO FORM A STRATEGIC PARTNERSHIP IN
GREATER CHINA
Source text for Eikon: ID:nCNW8WXQQa
Further company coverage: RP.V
((Bangalore.newsroom@thomsonreuters.com;;))
Recent news on Replicel Life Sciences
See all newsBrief: Replicel Life Sciences Announces Reinstatement Of Trading & Conditional Acceptance For Proposed Transaction
Brief: Replicel Life Sciences Says Replicel Announces A Letter Of Intent For Asset Purchase Agreement
Brief: Replicel Announces Binding Term Sheet For Strategic Investment And U.S. Partnership
Brief: Replicel Announces Its Incoming Board Of Directors
Brief: RepliCel Life Sciences Retains Dermatology Sales And Marketing Executive To Guide Global Commercial Strategy For Automated Dermal Injector